Clinical Trials Browser

Phase 1 × Precursor Cell Lymphoblastic Leukemia-Lymphoma × NVP-BKM120 × Clear all

NCT01396499 2016-11-01

Study to Assess Safety, Tolerability and Preliminary Efficacy of BKM120, PI3K Kinase Inhibitor, With Advanced Leukemias

Phase 1 Completed

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma